Is Bombay Super Hyb overvalued or undervalued?

As of 26 September 2025, the valuation grade for Bombay Super Hyb has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued based on its high valuation ratios. The PE ratio stands at 50.07, the Price to Book Value is 13.18, and the EV to EBITDA ratio is 42.66, all of which are significantly higher than industry norms.
In comparison to its peers, Bombay Super Hyb's valuation ratios are notably elevated. For instance, Jain Irrigation has a PE ratio of 110.1, while Indo US Bio-Tech shows a much lower PE of 14.77, highlighting the disparity in valuation within the sector. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -15.1% compared to the Sensex's gain of 4.27%. This further reinforces the assessment that Bombay Super Hyb is overvalued in the current market context.